Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells

Cinzia Casella1, Daniel H Miller1, Kerry Lynch1

  • 1Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02903, USA.

Gynecologic Oncology
|August 20, 2014
PubMed
Abstract

Insights

Oxysterols enhance statin effectiveness against ovarian cancer by increasing cell death. This novel STOX combination targets the mevalonate pathway, offering a promising new strategy for ovarian cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Statins are cholesterol-lowering drugs with potential anti-cancer properties.
  • Ovarian cancer remains a significant health challenge with limited treatment options.
  • Understanding drug mechanisms is crucial for developing more effective therapies.

Purpose of the Study:

  • To elucidate the mechanisms behind the enhanced efficacy of a novel statin-oxysterol combination (STOX) in ovarian cancer.
  • To investigate how oxysterols potentiate statin-induced cytotoxicity.

Main Methods:

  • Ovarian cancer cell lines were treated with statins and oxysterols.
  • Cell viability, apoptosis, and gene expression (mevalonate pathway, SREBP-2) were assessed.
  • siRNA-mediated gene silencing and protein prenylation assays were employed.

Main Results:

  • Oxysterols significantly increased statin-induced apoptosis and cytotoxicity in ovarian cancer cells.
  • STOX treatment led to decreased SREBP-2 expression, down-regulating the mevalonate pathway and enhancing statin toxicity.
  • Distinct mechanisms of statin toxicity were observed, involving protein geranylgeranylation and cholesterol homeostasis.

Conclusions:

  • The study reveals mechanisms of statin cytotoxicity in ovarian cancer cells.
  • The STOX combination represents a novel approach to enhance anti-tumor activity of statins.
  • This strategy may offer a new therapeutic avenue for ovarian cancer treatment.

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
5.1K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
57.9K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.0K
Ovaries01:26

Ovaries

The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
3.4K